Copyright
©The Author(s) 2016.
World J Gastroenterol. Mar 28, 2016; 22(12): 3341-3354
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3341
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3341
Figure 7 Effects of Auphen and dbcAMP on hepatocellular carcinoma in vivo.
A: mRNA levels of α-fetoprotein (AFP) in tumors from nude mice; B: AFP concentration in blood of control (NS), Auphen-treated (Auphen), and dbcAMP-treated (dbcAMP) groups. All data represent the mean ± SD (n = 3). bP < 0.01 vs the control; eP < 0.001 vs the control; C: Testing of apoptosis by TUNEL assay in tumor samples of nude mice in different treated groups (magnification, × 400). The nuclei of positive cells were stained brown; D: Tumor samples from nude mice in different treated groups (HE, magnification, × 400). Pathological traits of positive cells were revealed as karyopyknosis, and had a cytoplasmic red color.
- Citation: Peng R, Zhao GX, Li J, Zhang Y, Shen XZ, Wang JY, Sun JY. Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo. World J Gastroenterol 2016; 22(12): 3341-3354
- URL: https://www.wjgnet.com/1007-9327/full/v22/i12/3341.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i12.3341